Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Stoke Therapeutics (STOK) Receivables - Other (2022 - 2025)

Stoke Therapeutics has reported Receivables - Other over the past 4 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Receivables - Other at $2.0 million for Q4 2025, up 181.29% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 181.29% YoY), and the annual figure for FY2025 was $2.0 million, up 181.29%.
  • Receivables - Other for Q4 2025 was $2.0 million at Stoke Therapeutics, up from $1.6 million in the prior quarter.
  • Over the last five years, Receivables - Other for STOK hit a ceiling of $2.0 million in Q4 2025 and a floor of $11000.0 in Q1 2024.
  • Median Receivables - Other over the past 4 years was $443500.0 (2022), compared with a mean of $617437.5.
  • Biggest five-year swings in Receivables - Other: tumbled 97.76% in 2024 and later skyrocketed 5409.09% in 2025.
  • Stoke Therapeutics' Receivables - Other stood at $588000.0 in 2022, then plummeted by 89.12% to $64000.0 in 2023, then soared by 993.75% to $700000.0 in 2024, then skyrocketed by 181.29% to $2.0 million in 2025.
  • The last three reported values for Receivables - Other were $2.0 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.